FidoCure
FidoCure® uses genomic testing to identify possible cancer-causing mutations and then suggests targeted therapy to precisely attack the cancer cells. With FidoCure®, dogs with cancer receive access to the latest scientific advances in cancer care, from tests to treatment.
58.9
58.9
NaN
NaN
NaN
NaN
Valuation
$
Valuation
Funding
$
$ 10.00 M
$ 10.00 M
Funding
$ 10.00 M
$ 10.00 M
Statistics
NA
Ventures > FidoCure
FidoCure
Active
Action
FidoCure® uses genomic testing to identify possible cancer-causing mutations and then suggests targeted therapy to precisely attack the cancer cells. With FidoCure®, dogs with cancer receive access to the latest scientific advances in cancer care, from tests to treatment.
- Funding
0and0